ClinicalTrials.gg
CompletedNCT05374096Updated Jul 21, 2023

Study Exploring the Effect of Music on Pain After Ventral Hernia Surgery

An interventional study of Patient-Chosen Music and Placebo in Postoperative Pain, Acute, Ventral Hernia and Hernia Abdominal Wall, sponsored by The Cleveland Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-21.

Sponsored by The Cleveland Clinic · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
321
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to assess whether listening to music during surgery has an effect on pain or anxiety after surgery.

Read the detailed description

After being informed about the study and potential risks and meeting eligibility criteria, all patients giving written informed consent will be scheduled for their hernia repair surgery. On the day of surgery, patients will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to listen to patient-chosen music during their surgery via headphones or just listen to silence via headphones. Pain and anxiety will then be assessed after surgery.

02

Conditions studied

  • Postoperative Pain, Acute
  • Ventral Hernia
  • Hernia Abdominal Wall
  • Surgery
  • Anxiety

Keywords

  • Music
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 321 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

The Cleveland Clinic is the lead sponsor of 831 studies on the registry; 119 are open to participants now.

Of its 90 completed or terminated interventional studies of FDA-regulated products, 73 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults having open retromuscular ventral hernia repair with mesh, with or without myofascial release for a hernia width ≤ 20 cm
  2. Adults having open flank hernia repair that requires a myofascial release with mesh
  3. Adults having parastomal hernia repair with mesh

Exclusion criteria

Exclusion Criteria:

  1. Primary language other than English, or lack of English language fluency
  2. Hearing impairment, with or without use of hearing aids
  3. Neurologic condition that, in the opinion of the investigators, may preclude accurate assessment of postoperative pain and anxiety
  4. Patients who will remain intubated after surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
321 participants (actual)

Study arms

  • Experimental
    Music Via Headphones

    Headphones will be placed with patient-selected music playing for the duration of the surgical procedure.

    Other: Patient-Chosen Music

  • Placebo comparator
    Silence Via Headphones (Control)

    Headphones will be placed with silence for the duration of the surgical procedure.

    Other: Placebo

Interventions

  • OtherPatient-Chosen Music

    Music played into headphones.

  • OtherPlacebo

    Silence into headphones.

06

What researchers measure

Primary outcomes

  1. Post operative Pain

    Pain scores will be assessed using the Numeric Pain Rating Scale (NRS-11); The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")

    Time frame: At 24 hours (+- 3 hours) after surgery end time.

Secondary outcomes

  1. Post operative Anxiety

    Anxiety scores will be assessed using State Trait Anxiety Index-6 (STAI-6) Anxiety tool (a 6 question patient-reported anxiety assessment). The higher the total, the greater the anxiety is.

    Time frame: At 24 hours (+- 3 hours) after surgery end time.

Other outcomes

  1. Post operative Pain - 3 days

    Pain scores will be assessed using the Numeric Pain Rating Scale (NRS-11); The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")

    Time frame: Collected at 3 time points after surgery end time - 24 hours (+- 3 hours), 48 hours (+-3 hours) and 72 hours (+-3 hours)

  2. Post operative Pain - cumulative

    Pain scores will be assessed using the Numeric Pain Rating Scale (NRS-11); The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")

    Time frame: Will be collected repeatedly by nursing staff per nursing protocol for the first 24 hours after surgery end time.

  3. Post operative Anxiety - 3 days

    Anxiety scores will be assessed using State Trait Anxiety Index-6 (STAI-6) Anxiety tool (a 6 question patient-reported anxiety assessment). The higher the total, the greater the anxiety is.

    Time frame: Collected at 3 time points after surgery end time - 24 hours (+- 3 hours), 48 hours (+-3 hours) and 72 hours (+-3 hours)

  4. Post operative opioid consumption

    Cumulative opioid consumption converted into morphine milligram equivalents.

    Time frame: During the first 72 hours after surgery end time.

  5. Intraoperative sedative use

    Total number of intravenous and inhaled anesthetics, benzodiazepines, and opioid medications.

    Time frame: From induction of anesthesia to arrival in the post anesthesia care unit on the day of procedure

07

Study locations

1 site
  • Cleveland Clinic Main Campus
    Cleveland, Ohio 44195, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2022 to primary completion in Jul 2023, 13 months.

Of 2,089 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 13 months is above that.

Counting every sponsor, half of 2,102 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
May 2, 2022
First posted
May 16, 2022
StartActual
Jun 13, 2022
Primary completionActual
Jul 15, 2023
CompletionActual
Jul 17, 2023
Last update
Jul 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05374096
Responsible party
Ajita Prabhu, MD (Staff Physician, The Cleveland Clinic) — Principal investigator
First posted
May 16, 2022
Start date
Jun 13, 2022
Primary completion
Jul 15, 2023
Completion
Jul 17, 2023
Last update
Jul 21, 2023

Study contacts

Ajita Prabhu, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion